The oncogenic role of CB2 in the progression of non-small-cell lung cancer | |
Xu, Shaohua; Ma, Hanchen; Bo, Yuhong; Shao, Mingju | |
刊名 | BIOMEDICINE & PHARMACOTHERAPY |
2019 | |
卷号 | 117 |
关键词 | NSCLC CB2 Tumor progression Akt/mTOR/P70S6K pathway |
DOI | 10.1016/j.biopha.2019.109080 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4545809 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Dept Resp, Hosp 2, Jinan 250033, Shandong, Peoples R China. 2.Weihai Municipal Hosp, Weihai 26 |
推荐引用方式 GB/T 7714 | Xu, Shaohua,Ma, Hanchen,Bo, Yuhong,et al. The oncogenic role of CB2 in the progression of non-small-cell lung cancer[J]. BIOMEDICINE & PHARMACOTHERAPY,2019,117. |
APA | Xu, Shaohua,Ma, Hanchen,Bo, Yuhong,&Shao, Mingju.(2019).The oncogenic role of CB2 in the progression of non-small-cell lung cancer.BIOMEDICINE & PHARMACOTHERAPY,117. |
MLA | Xu, Shaohua,et al."The oncogenic role of CB2 in the progression of non-small-cell lung cancer".BIOMEDICINE & PHARMACOTHERAPY 117(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论